Sponsor
Enlitisa (Shanghai) Pharmaceutical Co. Ltd.
Room 201 202 203 Building A, Block1 No 800 Qingdai Road, 201318
About the sponsor
Research activity is centered on idiopathic pulmonary fibrosis, with a therapeutic focus on progressive interstitial lung disease and the mechanisms driving lung scarring and fibrotic remodeling.
- Idiopathic pulmonary fibrosis
- Interstitial lung disease
- Pulmonary fibrosis
The sponsor’s clinical interest lies in therapies relevant to chronic deterioration of pulmonary function and the management of fibrotic respiratory disorders.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.